Skip to main content
. 2021 Jul 23;12(3):500–525. doi: 10.1007/s13346-021-01024-2

Fig. 2.

Fig. 2

Representation of those critical material attributes (CMA) and critical process parameters (CPP) that cause discrepancy and variability of critical quality attributes (CQAs) during the rational design and production of nanomedicines